DIT vs GSK · P/E 173, rev $2.28B vs P/E 13, $103.31B cap
AMCON Distributing Company (DIT) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
AMCON Distributing Company (DIT) is a food distribution company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported DIT revenue for 2026-06-30 was $2.28B. Net income was $1.3M. Revenue was up 57.8% from 2026-03-31 to 2026-06-30. DIT currently screens at market cap $79.1M and trailing P/E 172.5.
GSK does not have a complete income-statement cache yet.
DIT currently screens at market cap $79.1M and trailing P/E 172.5. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the DIT and GSK stock pages for the full models.
Not investment advice.